Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

VLDLR / VLDL Receptor Antikörper

Produkt-Information von VLDLR / VLDL Receptor Antikörper

Immunogen

Recombinant Human VLDLR / VLDL Receptor protein (Catalog#11075-H08H)

Antibody Type Mouse Monoclonal Antibody ( Mouse mAb Service Platform )

Clone ID

04

Ig Type

Mouse IgG1

Formulation 0.2 μm filtered solution in PBS with 5% trehalose
Preparation

This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human VLDLR / VLDL Receptor (rh VLDLR / VLDL Receptor; Catalog#11075-H08H; NP_003374.3; Met 1-Ser 797). The IgG fraction of the cell culture supernatant was purified by Protein A affinity chromatography.

Usage Guide von VLDLR / VLDL Receptor Antikörper

Specificity

Human VLDLR / VLDL Receptor

 

No cross-reactivity in ELISA with

Human cell lysate (293 cell line)

Direct ELISA This antibody can be used at 0.5-1 μg/mL with the appropriate secondary reagents to detect Human VLDLR. The detection limit for Human VLDLR is approximately 0.039 ng/well.
Storage This antibody can be stored at 2℃-8℃ for one month without detectable loss of activity. Antibody products are stable for twelve months from date of receipt when stored at -20℃ to -70℃. Preservative-Free.
Sodium azide is recommended to avoid contamination (final concentration 0.05%-0.1%). It is toxic to cells and should be disposed of properly. Avoid repeated freeze-thaw cycles.

Hintergrund von VLDLR / VLDL Receptor Antikörper

Related Areas:

Cardiovascular>>Lipid Metabolism>>VLDLR/VLDL Receptor

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
VLDLR/VLDL Receptor Human VLDLR/VLDL Receptor Protein, Recombinant 11075-H08H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Human
VLDLR/VLDL Receptor
WB VLDLR / VLDL Receptor Antibody 11075-MM01
Human
VLDLR/VLDL Receptor
ELISA VLDLR / VLDL Receptor Antibody 11075-MM04
Human
VLDLR/VLDL Receptor
WB, ELISA VLDLR/VLDL Receptor Antibody, Rabbit PAb 11075-RP01
Human
VLDLR/VLDL Receptor
WB, ELISA VLDLR/VLDL Receptor Antibody, Rabbit PAb (Antigen Affinity Purified) 11075-RP02

Hintergrund von VLDLR / VLDL Receptor Antikörper

The very low density lipoprotein receptor, known as VLDLR, is a single-pass type 1 integral membrance protein and a member of the LDL receptor family. This receptor family includes LDL receptor, LRP, megalin, VLDLR and ApoER2, and is characterized by a cluster of cysteine-rich class A repeats, epidermal growth factor (EGF)-like repeats, YWTD repeats and an O-linked sugar domain. VLDLR contains 3 EGF-like domains, 8 LDL-receptor class A domains, as well as 6 LDL-receptor class B repeats, and is abundant in heart, skeletal muscle, also ovary and kidney, but not in liver. VLDLR binds VLDL and transports it into cells by endocytosis. In order to be internalized, the receptor-ligand complexes must first cluster into clathrin-coated pits. VLDLR mediates the phosphorylation of mDab1 (mammalian disabled protein) via binding to Reelin, and induces the modulation of Tau phosphorylation. This pathway regulates the migration of neurons along the radial glial fiber network during brain development. Defects of VLDLR may be the cause of VLDLR-associated cerebellar hypoplasia (VLDLRCH), a syndrome characterized by moderate-to-profound mental retardation, delayed ambulation, and predominantly truncal ataxia.

References

  1. Trommsdorff, M. et al., 1999. Cell. 97: 689-701.
  2. Mikhailenko, I. et al., 1999. J. Cell Sci. 112: 3269-3281.
  3. Sato, A. et al., 1999. Biochem. J. 341: 377-383.
  4. Hiesberger, T. et al., 1999. Neuron 24: 481-489.
  5. Tiebel, O. et al., 1999. Atherosclerosis 145: 239-251.
  6. Boycott, K.M. et al., 2005,Am. J. Hum. Genet.77 (3): 477-483.
  7. Moheb, L.A. et al., 2008, Eur. J. Hum. Genet.16 (2): 270-273.

Sino Biological Inc. liefert VLDLR / VLDL Receptor Antikörper mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über VLDLR / VLDL Receptor Antikörper lesen Sie bitte: http://www.sinobiological.com/VLDLR-VLDL-Receptor-Antibody-g-9520.html

Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post